Edition:
United Kingdom

Reata Pharmaceuticals Inc (RETA.OQ)

RETA.OQ on NASDAQ Stock Exchange Global Market

25.76USD
3:28pm GMT
Change (% chg)

$0.18 (+0.70%)
Prev Close
$25.58
Open
$25.61
Day's High
$25.81
Day's Low
$25.36
Volume
4,502
Avg. Vol
64,531
52-wk High
$40.56
52-wk Low
$19.85

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 12.56 -0.495
Jun '17 12.81 -0.518
Mar '17 12.73 -0.318
FY 2016 Dec '16 12.50 -0.185
Sep '16 12.55 -0.040
Jun '16 12.37 -0.050
Mar '16 12.44 -0.013
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 2 9.77 12.50 7.05 12.50
Quarter Ending Jun-18 2 9.77 12.50 7.05 12.50
Year Ending Dec-18 7 47.01 50.50 28.18 42.76
Earnings (per share)
Quarter Ending Mar-18 4 -0.57 -0.45 -0.78 -0.28
Quarter Ending Jun-18 4 -0.57 -0.42 -0.73 -0.29
Year Ending Dec-18 8 -2.42 -1.58 -2.97 -1.47
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 83.93 32.90
P/E High - Last 5 Yrs. -- 292.71 45.97
P/E Low - Last 5 Yrs. -- 91.44 24.37
Beta -- 0.90 0.89
Price to Sales (TTM) 16.46 110.72 5.77
Price to Book (MRQ) -- 13.56 5.41
Price to Tangible Book (MRQ) -- 14.02 6.98
Price to Cash Flow (TTM) -- 71.33 23.42
% Owned Institutions 38.46 12.89 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.66 5.21
Payout Ratio(TTM) -- 15.70 43.72

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 3.56 398.33 9.24
Sales (TTM) vs TTM 1 Yr. Ago 1.53 78.63 5.59
Sales - 5 Yr. Growth Rate -- 32.11 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago -927.87 25.10 19.65
EPS (TTM) vs TTM 1 Yr. Ago -792.05 -- --
EPS - 5 Yr. Growth Rate -- 38.95 10.73
Capital Spending - 5 Yr. Growth Rate -- 40.24 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.18
Current Ratio (MRQ) 1.34 5.30 2.97
LT Debt to Equity (MRQ) -- 22.82 12.22
Total Debt to Equity (MRQ) -- 24.47 16.52
Interest Coverage (TTM) -- -98.78 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.03 54.70
Gross Margin - 5 Yr. Avg. -- 51.06 52.42
EBITD Margin (TTM) -45.39 -- --
EBITD - 5 Yr. Avg -- -572.68 10.86
Operating Margin (TTM) -46.57 -717.10 4.64
Operating Margin - 5 Yr. Avg. -- -594.00 6.26
Pre-Tax Margin (TTM) -46.88 -691.66 5.44
Pre-Tax Margin - 5 Yr. Avg. -- -597.35 6.60
Net Profit Margin (TTM) -46.89 -692.88 1.76
Net Profit Margin - 5 Yr. Avg. -- -600.21 2.91
Effective Tax Rate (TTM) -- 22.57 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.19 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 674,533 22,602,121 855,668,157
Net Income/Employee (TTM) -316,293 2,968,747 100,655,595
Receivable Turnover (TTM) -- 20.14 5.78
Inventory Turnover (TTM) -- 2.36 3.35
Asset Turnover (TTM) 0.54 0.39 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -25.54 -1.05 10.98
Return on Assets - 5 Yr. Avg. -- -0.57 12.37
Return on Investment (TTM) -63.77 1.66 14.43
Return on Investment - 5 Yr. Avg. -- 2.23 16.18
Return on Equity (TTM) -- 2.58 16.13
Return on Equity - 5 Yr. Avg. -- 3.13 17.47
  1 Year 3 Year 5 Year
Sales % -0.92 -0.88 --
EPS (TTM) % -333.36 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Reata Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 66.33%
# of Holders: 132
Total Shares Held: 13,161,419
3 Mo. Net Change: 2,523,986
# New Positions: 18
# Closed Positions: 11
# Increased Positions: 73
# Reduced Positions: 39
# Net Buyers: 34
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.